MeDiCa 0608-MI
MeDiCa 0608-MI is a Class II device made by Scimedx Corp., cleared under FDA 510(k) K843343 on 22 Oct 1984 and listed in FDA GUDID since 1 Dec 2020 (UDI-DI 00813545026738), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00813545026738 | Date1 Dec 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK843343 | Date22 Oct 1984 | StatusActive |
Official records
- AccessGUDID record 00813545026738
- FDA 510(k) database K843343
Across registries
- FDA 510(k) K843343 decided 22 Oct 1984 Active
- FDA GUDID UDI-DI 00813545026738 listed 1 Dec 2020 Listed
Timeline
- Cleared FDA 510(k) K843343
- Listed FDA GUDID 00813545026738
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- MeDiCa
- Generic name
- Multiple thyroid antibody IVD, kit, fluorescent immunoassay
- Model / Ref / Catalog
- 0608-MI
- Primary DI / UDI-DI
- 00813545026738
- 510(k) Number
- FDA product code
- JZO
- GMDN term
- Multiple thyroid antibody IVD, kit, fluorescent immunoassay
- Device class
- Class II
- Regulation number
- 866.5870
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code JZO (System, Test, Thyroid Autoantibody).
- Thyretain 40-25000.V2 by DIAGNOSTIC HYBRIDS, INC.
- DIASTAT ANTI-THYROID PEROXIDASE ELISA MODEL #300 by Axis-Shield Diagnostics Limited
- Elecsys Anti-Tg by Roche Diagnostics Corp.
- ARCHITECT 2K46-20 02K4620 by Abbott Ireland Diagnostics
- ARCHITECT 2K46-25 02K4625 by Abbott Ireland Diagnostics
- ELECSYS ANTI-THYROID PEROXIDASE ANTIBODY TEST SYSTEM by Roche Diagnostics Corp.
- BRAHMS DIAGNOSTICA LUMITEST TRAK HUMAN by Brahms Diagnostica, LLC
- ANTI-THYROGLOBULIN TEST KIT by KRONUS, INC.
- IMMUNOWELL THYROGLOBULIN TEST by General Biometrics, Inc.
- SERAQUEST ANTI-THYROID PEROXIDASE (TPO) by Quest Intl., Inc.